Skip to main content

Part of the book series: Onkologie heute ((ONKOLOGIE))

  • 27 Accesses

Zusammenfassung

Die Urogenitalen Carcinome beim Mann (Carcinome des Hodens, der Prostata, der Blase und der Niere) und bei der Frau (Carcinome der Cervix, des Corpus, des Ovars, der Blase und der Niere) stellen eine bedeutende Krankheitsgruppe dar. In den Ländern der Europäischen Union beträgt der Anteil dieser Carcinome an allen Neuerkrankungen bei den Männern 27%, bei den Frauen 19%. Der entsprechende Anteil an allen Krebstodesfällen beträgt bei den Männern 18%, bei den Frauen 15% (Angaben für 1995, Quelle: IARC, 1999). Trendanalysen werden am Beispiel österreichischer Daten dargestellt. Die Hinweise auf die Ätiologie beziehen sich in erster Linie auf exogene Noxen.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 29.99
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 44.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

Literatur

  1. Bosch FX, Munoz N, de Sanjos S, et al. (1994) Importance of human papillomavirus endemicity in the incidence of cervical cancer: An extension of the hypothesis on sexual behaviour. Cancer Epidemiol Biomarkers Prev 3: 375–379.

    PubMed  CAS  Google Scholar 

  2. Coleman MP, Esteve J, Damiecki P, et al. (1993) Trends in Cancer Incidence and Mortality (IARC Scientific Publications No 121). International Agency for Research on Cancer, Lyon.

    Google Scholar 

  3. Franco E, Syrjänen K, de Wolf Ch, et al. (1996) New developments in cervical cancer screening and prevention. Cancer Epidemiol Biomarkers Prev 5: 853–856.

    PubMed  CAS  Google Scholar 

  4. Glud E, Krüger S, Troisi R, et al. (1998) Fertility drugs and ovarian cancer. Epidemiologic Rev 20: 237–257.

    Article  CAS  Google Scholar 

  5. Hankey BF, Feuer EJ, Clegg LX, et al. (1999) Cancer surveillance series: Interpreting trends in prostate cancer-Part I: Evidence of the effects of screening in recent prostate cancer incidence, mortality, and survival rates. J Natl Cancer Inst 91: 1017–1024.

    Article  PubMed  CAS  Google Scholar 

  6. Koning HJ, de Schröder FH (1998) PSA-Screening for prostate cancer. The current controversy. Ann Oncol 9: 1293–1296.

    Article  PubMed  Google Scholar 

  7. Mannetje A, Kogevinas M, Chang C (1999) Occupation in bladder cancer in European women. Cancer Causes Control 10: 209–217.

    Article  PubMed  CAS  Google Scholar 

  8. Recommendations on Cancer Screening in the European Union: Conference on Screening and Early Detection of Cancer, Vienna, Nov. 18–19, 1999.

    Google Scholar 

  9. Seidler A, Heiskel H, Bickeboller R, et al. (1998) Association between diesel exposure at work and prostate cancer. Scand J Work Environ Health 24: 486–494.

    Article  PubMed  CAS  Google Scholar 

  10. Simons AM, Mugica van Heckenrode C, Rodriguz JA, et al. (1995) Demonstration of smoking related DNA damage in cervical epithelium and correlation with human papillomavirus typ 16, using exfoliative cervical cells. Br J Cancer 71: 246–249.

    Article  PubMed  CAS  Google Scholar 

  11. Sourander L, Rajala T, Räihä I, et al. (1998) Cardiovascular and cancer morbidity and mortality and sudden cardiac death in postmenopausal women on oestrogen replacement therapy (ERT). Lancet 352: 1965–1969.

    Article  PubMed  CAS  Google Scholar 

  12. US Surgeon General (1979) Smoking and Health. US Department of Health, Education and Welfare, Washington DC, USA, S. 5–45.

    Google Scholar 

  13. Vogelzang NJ, Stadler WM (1998) Kidney cancer. Lancet 352: 1691–1696.

    Article  PubMed  CAS  Google Scholar 

  14. Vutuc Ch, Haidinger G, Waldhoer T, et al. (1999) Prevalence of self-reported cervical cancer screening and impact on cervical cancer mortality in Austria. Wien Klin Wochenschr 111: 354–359.

    PubMed  CAS  Google Scholar 

  15. Vutuc Ch, Madersbacher St, Waldhoer Th, et al. (in Vorbereitung) Prostate cancer in Austria: PSA-screening and impact on mortality.

    Google Scholar 

  16. Weiderpass E, Baron J, Adami HO, et al. (1999) Low-potency oestreogen and risk of endometrial cancer: A case control study. Lancet 353: 1824–1828.

    Article  PubMed  CAS  Google Scholar 

  17. World Cancer Research Fund — American Institute of Cancer Research (1997) Food, Nutrition and the Prevention of Cancer: A Global Perspective. Banta Book Group, Mebasha,USA, S. 310.

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 2001 Springer-Verlag Wien

About this chapter

Cite this chapter

Vutuc, C., Haidinger, G. (2001). Epidemiologie. In: Zielinski, C., Jakesz, R. (eds) Urogenitale Carcinome. Onkologie heute. Springer, Vienna. https://doi.org/10.1007/978-3-7091-6193-7_1

Download citation

  • DOI: https://doi.org/10.1007/978-3-7091-6193-7_1

  • Publisher Name: Springer, Vienna

  • Print ISBN: 978-3-211-83528-9

  • Online ISBN: 978-3-7091-6193-7

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics